Detailed View
IPSC - Century Therapeutics, Inc.
Latest filing: 2025-12-31 | Reporting: gaap
Market Cap
436,726,304
Adj EBIT (TTM)
-17,269,000
Enterprise Value
319,612,304
Last Price
2.43
Earnings Yield
-5.40%
Return on Capital
-10.20%
Capital
169,278,000
1Y Price Chart
Last Price: $2.43
1Y Change: 307.72%
As of 2026-03-16 | 1Y Change: 307.72%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2025-12-31 | 10-K (Q4 derived) | 2025 | -109,164,000 | -20,657,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -36,124,000 |
| 2025-06-30 | 10-Q | 2025 | 109,164,000 | -34,664,000 |
| 2025-03-31 | 10-Q | 2025 | 109,164,000 | 74,176,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 4,172,000 | -37,284,000 |
| 2024-09-30 | 10-Q | 2024 | 791,000 | -34,789,000 |
| 2024-06-30 | 10-Q | 2024 | 771,000 | -34,755,000 |
| 2024-03-31 | 10-Q | 2024 | 855,000 | -31,309,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.